These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2575225

  • 1. Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies.
    De Souza EB, Battaglia G.
    NIDA Res Monogr; 1989; 94():196-222. PubMed ID: 2575225
    [Abstract] [Full Text] [Related]

  • 2. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 3. Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies.
    De Souza EB, Battaglia G, Insel TR.
    Ann N Y Acad Sci; 1990 Sep; 600():682-97; discussion 697-8. PubMed ID: 1979218
    [Abstract] [Full Text] [Related]

  • 4. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
    Schmidt CJ.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):1-7. PubMed ID: 2433425
    [Abstract] [Full Text] [Related]

  • 11. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R, Kerans A, O'Neill B, Harkin A.
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [Abstract] [Full Text] [Related]

  • 12. Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine.
    Zaczek R, Hurt S, Culp S, De Souza EB.
    NIDA Res Monogr; 1989 Jan; 94():223-39. PubMed ID: 2575226
    [Abstract] [Full Text] [Related]

  • 13. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM, Johnson M, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [Abstract] [Full Text] [Related]

  • 14. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
    Battaglia G, Sharkey J, Kuhar MJ, de Souza EB.
    Synapse; 1991 Aug; 8(4):249-60. PubMed ID: 1681594
    [Abstract] [Full Text] [Related]

  • 15. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    Slikker W, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM.
    Neurotoxicology; 1989 Aug; 10(3):529-42. PubMed ID: 2576304
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems.
    Battaglia G, De Souza EB.
    NIDA Res Monogr; 1989 Aug; 94():240-58. PubMed ID: 2514364
    [Abstract] [Full Text] [Related]

  • 17. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.
    Gollamudi R, Ali SF, Lipe G, Newport G, Webb P, Lopez M, Leakey JE, Kolta M, Slikker W.
    Neurotoxicology; 1989 Aug; 10(3):455-66. PubMed ID: 2576302
    [Abstract] [Full Text] [Related]

  • 18. (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.
    Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW.
    JAMA; 1988 Jul 01; 260(1):51-5. PubMed ID: 2454332
    [Abstract] [Full Text] [Related]

  • 19. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Mar 01; 244(3):977-82. PubMed ID: 2472482
    [Abstract] [Full Text] [Related]

  • 20. Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.
    Davis WM, Hatoum HT, Waters IW.
    Alcohol Drug Res; 1987 Mar 01; 7(3):123-34. PubMed ID: 2881551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.